Bladder CA Flashcards

1
Q

Give me the TNM for bladder CA

A

Tis: CIS
Ta: superficial
T1: invades lamina propria
T2: invades muscular wall (a: inner, b: outer)
T3: invades perivesical fat (a: micro b: macro)
T4: (a)adjacent structures/(b)pelvic wall

N1: 1 node near bladder
N2: more than one node near bladder
N3: node in abdomen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are risk factors for bladder CA?

A

Male > female, age, tobacco abuse, schistomiosis, radiation, chemical exposure (aromatic compounds), cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What metastatic imaging must have been performed in all bladder CA patients?

A

Upper tract imaging (CT preferred, but a lot will have had it done as part of hematuria workup)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is risk stratification for bladder CA

A

Low risk: LG Ta</= 3cm, PUNLMP

Medium risk: recurrent LG Ta within one year, LG Ta > 3cm, HG Ta </=3cm, multifocal LG Ta, LG T1

High risk: HG Ta >/= 3cm, HGT1, recurrent HG Ta, CIS, BCG failure in HG patient, variant histology, LVI, or HG prostatic involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some variants?

A

micro papillary, sarcamatoid, nested, plasmacytoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are important things to do for variant histology bladder CA?

A

Review with a GU pathologist.
Re-TURBT in 4-6 weeks if planning bladder sparing approach vs up front cystectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the different types of urine biomarkers for bladder CA, and what are they useful for?

A

NMP22
BTA
FISH
ImmunoCyt
CxBladder

Mainly useful for IR and HR disease, to assess response to intravesical BCG (FISH), and for equivocal cytology (ImmunoCyt and FISH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When should re-resection be performed?

A

incomplete resection
high risk HGTa or HGT1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When should mitomycin C be given?

A

in patients with LR or IR disease after TURBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are chances for low risk disease to recur?

A

30-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some BCG side effects?

A

sepsis, granulamtous prostatitis (and cystitis / orchitis), dysuria, hematuria, irritative voiding symptoms (tx with NSAID, anticholinergics, Pyridium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How to treat BCG sepsis?

A

Steroids + NSAIDs + RIPE
pyridoxine prevents peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens if only persistent fever or UTI after BCG?

A

isoniazid x 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which patients is BCG not good for?

A

Patients that don’t have an intact immune system (patients on chronic steroids for RA or mAB) - can use mitomycin C for these patientsW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What to treat patient that is BCG refractory CIS and HR disease, but not surgical candidate?

A

Valrubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What chance for recurrence in HR disease?

A

60-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How long for maintenance therapy in patients of IR and HR?

A

IR - 3 weeks at 3,6,12 moths for a year
HR - 3 weeks every 3,6,12,18,24,30,36 for 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which patient should get a second try at BCG if the first one had recurrence?

A

Ta or CIS
can be either six week induction or three week maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What about persistent disease in a patient with HR T1 disease?

20
Q

How soon is high grade recurrence to show up where you don’t offer anymore BCG?

A

Two cycles of BCG, within 6 months

21
Q

What to do if recurrence within 12 months?

A

clinical trial enrollment (if not cystectomy eligible) or try intravesical gemcitabine/docetaxel

22
Q

What about recurrence for CIS in 12 months?

A

pembro or intravesical valrubicin

23
Q

What is surveillance for each?

A

LR - cysto - 3 months, 6-9 months later, than yearly (up until 5 years)
IR and HR - cysto/cyto - q3 months for two years, q6 months for 2 years, then yearly

For IR and HR - upper tract imaging ever 1-2 years

24
Q

What should you do every time you do a TURBT?

A

EUA - check to see if it is fixated disease

25
If found to have MIBC, what staging do you need to do?
CBC, CMP, Alk Phos, LFT, CXR (or Chest CT), CT A/P w/ IV contrast
26
What are you looking for on imaging?
extent of local disease to safely remove bladder, hydronephrosis, lymph nodes, distant mets, and upper tract disease
27
What are general ideal characteristics for a patient to undergo bladder preservation strategies for MIBC?
unifocal disease, can be fully resected, no hydronephrosis, LIMITED CIS remember, must get all team involved - med Onc, rad Onc, and urology
28
What must effects on QoL must you talk to patients for MIBC treatment?
sexual function, fertility, continence, metabolic dysfunction, bowel function (can have ileus, recurrent infections etc)
29
What are some contraindications for NAC?
poor ECOG >/= 2 hearing loss in one ear poor CrCL < 60 severe heart failure peripheral neuropathy
30
How soon to do cystectomy after NAC?
about 12 weeks
31
What happens if you are identified to have pT3/T4 or N disease after surgery?
For those who did not get NAC, get adjuvant chemotherapy or immunotherapy. For those who did get NAC, get adjuvant immunotherapy (nivolumab)
32
What do you counsel patient between bladder preservation vs cystectomy?
That the 5 year, 10 year survival rates are better with cystectomy. 28% vs 47%.
33
Can you preserve female reproductive organs?
If maintaining fertility is important, and cancer can be controlled, can do uterine / ovarian / vagina (anterior wall) sparing. If not important to maintain fertility, but still want to spare uterus, should still perform salpingectomy.
34
When do you do urethrectomy?
if the apical urethral margin is positive (can be immediate or delayed). Must always check for negative margin in neobladder patients.
35
What are contraindications to continent channels?
Poor hepatic and renal function (GFR < 45) Short bowel length Poor dexterity or psychological issues Postive urethral margin significant urethral stricture disease
36
If neobladder to be considered, what needs to be confirmed
negative urethral margin for females - if palpable mass (T3b) - then needs urethral AND vaginal margins
37
What else must you do to prepare patients for cystectomy?
Ostomy teaching!!!
38
What are boundaries of PLND?
Limited - genitofemoral, node of cloquet, obdurate nerve / external iliac, common iliac bifurcation (external iliac + obdurator nodes) Standard - common iliac bifurcation, bladder, obdurate / external iliac, node of cloquet (external iliac, obdurator, internal iliac (hypogastric)) - need at least 12 nodes
39
Which types of bladder CA are not ideal for bladder sparing?
cannot resect entire tumor, T3/T4, multifocal CIS, hydronephrosis
40
What kind of chemo is radiosensitive and good for trimodal therapy?
cisplatin or 5FU + mitomycin C or gemcitaibine
41
How should you survey?
Just survey like HR disease
42
What is surveillance / follow up after cystectomy?
chest imaging and CT A/P every six months for 2-3 years Labs - CMP every 3-6 months for two years then annually afterwards. consider B12 if heavy terminal ileum use cytology is not verified for use
43
What is chance for urethral recurrence
10% Monitor with urethral washes - cytology and physical exams, as needed
44
What are some metabolic derangement post urinary diversion?
Stones, electrolyte abnormalities, hepatic issues (ammonia), metabolic acidosis, short bowel syndrome
45
What do you counsel patients on continence with a neobladder?
Daytime continence is fine Nightlight continence is around 50% (due to loss of afferent input)